Loading...
Q32 Bio Inc.
QTTB•NASDAQ
Healthcare
Biotechnology
$2.69
$1.18(78.15%)
Q32 Bio Inc. (QTTB) Financial Performance & Statements
Review Q32 Bio Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
100.00%
↑ 100.00%
Operating Income Growth
-36.98%
↓ 36.98%
Net Income Growth
11.18%
↑ 11.18%
Operating Cash Flow Growth
29.63%
↑ 29.63%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-447.33%
↓ 447.33%
ROIC
-98.44%
↓ 98.44%
Q32 Bio Inc. (QTTB) Financial Statements
Explore quarterly and annual reports for Q32 Bio Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $121000.00 | $123000.00 |
| Gross Profit | $0.00 | $0.00 | -$121000.00 | -$123000.00 |
| Gross Profit Ratio | ||||
| R&D Expenses | $10.54M | $14.35M | $13.41M | $9.84M |
| SG&A Expenses | $3.98M | $4.47M | $4.39M | $5.002M |
| Operating Expenses | $14.53M | $18.81M | $17.80M | $14.84M |
| Total Costs & Expenses | $14.53M | $18.81M | $17.92M | $14.84M |
| Interest Income | $0.00 | $0.00 | $4.09M | $0.00 |
| Interest Expense | $0.00 | $0.00 | $1.70M | $0.00 |
| Depreciation & Amortization | $120000.00 | $123000.00 | $121000.00 | $123000.00 |
| EBITDA | $6.71M | -$18.69M | -$17.80M | -$14.72M |
| EBITDA Ratio | ||||
| Operating Income | -$14.53M | -$18.81M | -$17.92M | -$14.84M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $358000.00 | $1.22M | $2.39M | $16.05M |
| Income Before Tax | -$14.17M | -$17.59M | -$15.53M | $1.21M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $21000.00 | $0.00 | $1.45M | -$15.71M |
| Net Income | -$14.19M | -$17.59M | -$16.98M | $1.03M |
| Net Income Ratio | ||||
| EPS | -$2.48 | -$1.46 | -$1.42 | $0.09 |
| Diluted EPS | -$2.48 | -$1.46 | -$1.42 | $0.09 |
| Weighted Avg Shares Outstanding | $12.18M | $12.08M | $11.96M | $3.21M |
| Weighted Avg Shares Outstanding (Diluted) | $12.18M | $12.08M | $11.96M | $3.21M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan